Sunhawk Vision Biotech, Inc. (TPEX:7759)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.70
-0.65 (-2.14%)
At close: Aug 26, 2026

Sunhawk Vision Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-131.82-172.39-87.85-25.1
Depreciation & Amortization
5.995.714.711.32
Other Amortization
0.040.040.040.06
Loss (Gain) From Sale of Assets
0.260.260.68-
Other Operating Activities
-0.05-0.790.21-72.87
Change in Accounts Payable
2.4318.16-4.54-43.82
Change in Other Net Operating Assets
17.334.12-8.2565.29
Operating Cash Flow
-105.82-144.89-95.01-75.11
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.13-0.42-1.06-3.13
Sale (Purchase) of Intangibles
----0.19
Investment in Securities
20091.4-37.9-12.54
Other Investing Activities
-0.04-0.21-0.69-0.33
Investing Cash Flow
199.8390.77-39.64-16.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Long-Term Debt Repaid
--4.26-2.86-0.57
Net Debt Issued (Repaid)
-4.59-4.26-2.86-0.57
Issuance of Common Stock
4.11347.874219.39
Financing Cash Flow
-0.48343.5371.14218.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Foreign Exchange Rate Adjustments
1.070.21-0.170.75
Net Cash Flow
94.6289.62-63.67128.26

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-105.95-145.31-96.06-78.24
Free Cash Flow Growth
----
Free Cash Flow Per Share
-1.52-2.08-1.54-1.27
Levered Free Cash Flow
-64.52-82.76-72.86-
Unlevered Free Cash Flow
-64.43-82.65-72.74-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
0.180.180.190.02
Cash Income Tax Paid
0.750.750.510.06
Change in Working Capital
19.7522.28-12.7821.47